HER3 Targeting Augments the Efficacy of Panobinostat in Claudin-Low Triple-Negative Breast Cancer Cells

RNA sequencing analyses of the claudin-low TNBC cells untreated or treated with panobinostat were performed to identify the differentially expressed genes.